Yantai Dongcheng Pharmaceutical Co Ltd
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluro… Read more
Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.014x
Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.014x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.53 Million) by net assets (CN¥5.45 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yantai Dongcheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Axogen Inc
NASDAQ:AXGN
|
0.027x |
|
CPFL Energia S.A
SA:CPFE3
|
0.053x |
|
Societatea Nationala de Transport Gaze Naturale Transgaz SA
RO:TGN
|
0.016x |
|
JUSUNG ENGINEERING Co. Ltd
KQ:036930
|
-0.027x |
|
RED CAT HDGS INC.DL -001
F:BQ73
|
N/A |
|
Beijing YanDong MicroElectronic Co. Ltd. A
SHG:688172
|
N/A |
|
Shandong Humon Smelting Co Ltd
SHE:002237
|
0.212x |
|
S&T Bancorp Inc
NASDAQ:STBA
|
0.028x |
Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.37 Billion | CN¥287.15 Million | 0.053x | +4.15% |
| 2023-12-31 | CN¥5.40 Billion | CN¥276.94 Million | 0.051x | -72.79% |
| 2022-12-31 | CN¥5.28 Billion | CN¥996.54 Million | 0.189x | +0.44% |
| 2021-12-31 | CN¥5.02 Billion | CN¥943.58 Million | 0.188x | +62.89% |
| 2020-12-31 | CN¥4.97 Billion | CN¥572.58 Million | 0.115x | -20.87% |
| 2019-12-31 | CN¥4.78 Billion | CN¥696.38 Million | 0.146x | +36.26% |
| 2018-12-31 | CN¥4.61 Billion | CN¥493.06 Million | 0.107x | +68.33% |
| 2017-12-31 | CN¥3.29 Billion | CN¥208.94 Million | 0.064x | -0.18% |
| 2016-12-31 | CN¥3.08 Billion | CN¥196.28 Million | 0.064x | +113.39% |
| 2015-12-31 | CN¥2.24 Billion | CN¥66.69 Million | 0.030x | -32.08% |
| 2014-12-31 | CN¥1.18 Billion | CN¥52.00 Million | 0.044x | +334.72% |
| 2013-12-31 | CN¥1.10 Billion | CN¥-20.60 Million | -0.019x | -142.66% |
| 2012-12-31 | CN¥1.02 Billion | CN¥44.53 Million | 0.044x | -90.38% |
| 2011-12-31 | CN¥304.42 Million | CN¥138.83 Million | 0.456x | +52.81% |
| 2010-12-31 | CN¥191.06 Million | CN¥57.02 Million | 0.298x | +257.54% |
| 2009-12-31 | CN¥140.43 Million | CN¥-26.60 Million | -0.189x | -136.16% |
| 2008-12-31 | CN¥79.34 Million | CN¥41.57 Million | 0.524x | -- |